Literature DB >> 9858347

Quinolone-resistant Neisseria gonorrhoeae: the beginning of the end? Report of quinolone-resistant isolates and surveillance in the southwestern United States, 1989 to 1997.

J M Ehret1, F N Judson.   

Abstract

BACKGROUND: Fluoroquinolones are one of the most widely used treatments for gonorrhoeae. Changes in the susceptibility of Neisseria gonorrhoeae to these agents may threaten their use. GOAL OF THIS STUDY: To report several resistant strains (>1 mcg/ml) isolated in the western United States and to evaluate the prevalence of strains with reduced susceptibility (ofloxacin 0.25 mcg/ml, ciprofloxacin 0.06 mcg/ml). STUDY
DESIGN: The microbiology and epidemiology of three resistant strains were characterized and 12,761 other strains were evaluated for fluoroquinolone susceptibility as part of the Gonococcal Isolate Surveillance Project of the Centers for Disease Control and Prevention.
RESULTS: Fluoroquinolone-resistant strains may appear sporadically. The prevalence of isolates with reduced susceptibility to fluoroquinolones remains low in the Southwest region of the United States.
CONCLUSIONS: Continued active surveillance is needed to detect and control the spread of quinolone-resistant Neisseria gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858347     DOI: 10.1097/00007435-199811000-00005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  2 in total

1.  Secular trends of gonorrhea in young adults in Israel: three decades of follow-up.

Authors:  D Mimouni; Y Bar-Zeev; N Davidovitch; M Huerta; R D Balicer; H Levine; O Ankol; I Grotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-29       Impact factor: 3.267

2.  The fall and rise of gonorrhoea incidence in Israel: an international phenomenon?

Authors:  M S Green; E Anis; D Gandacu; I Grotto
Journal:  Sex Transm Infect       Date:  2003-04       Impact factor: 3.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.